Related Experiment Video
Updated: Sep 27, 2025
11:53
Simultaneous Isolation and Culture of Atrial Myocytes, Ventricular Myocytes, and Non-Myocytes from an Adult Mouse Heart
Published on: June 14, 2020
7.6K
Future Directions in Cardiac Amyloidosis
1Houston Methodist Heart & Vascular Center, JC Walter Houston Methodist Transplant Center, Houston Methodist Hospital, Houston, Texas, US.
Methodist Debakey Cardiovascular Journal
|April 13, 2022
Summary
Cardiac amyloidosis (CA) diagnosis and treatment have advanced significantly. Improved diagnostics and therapies for transthyretin amyloid cardiomyopathy (ATTR-CM) are enhancing patient survival and offering new hope.
Area of Science:
- Cardiology
- Genetics
- Medical Diagnostics
Background:
- Cardiac amyloidosis (CA) was historically underdiagnosed with limited treatment options.
- Transthyretin amyloid cardiomyopathy (ATTR-CM) diagnosis is increasing due to improved awareness and diagnostic tools.
Purpose of the Study:
- To highlight the advancements in diagnosing and treating cardiac amyloidosis.
- To discuss the evolving landscape of ATTR-CM management and future therapeutic directions.
Main Methods:
- Increased utilization of genetic testing and nuclear scintigraphy.
- Recognition of associated conditions like carpal tunnel syndrome and lumbar stenosis.
- Multidisciplinary involvement of specialists in diagnosis.
Main Results:
- Growing number of ATTR-CM diagnoses.
- Improved survival rates and expanded treatment options beyond hospice or transplant.
- Emergence of new therapeutic strategies targeting amyloid fibrils.
Conclusions:
- A new era in cardiac amyloidosis treatment has begun with better diagnostics and therapies.
- Future research aims for therapies to remove amyloid deposits and potential genetic cures for ATTR carriers.
More Related Videos
Related Concept Videos
01:30Cardiomyopathy II: Dilated Cardiomyopathy
43
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
43
01:29Cardiomyopathy V: Interprofessional Care
51
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
51
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
75
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
75
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
57
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
57
01:25Cardiomyopathy I: Introduction and Classification
93
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
93
01:21Myocarditis I: Introduction
52
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
52